Elizabeth Buck
Founder at BLACK DIAMOND THERAPEUTICS, INC.
Net worth: 482 623 $ as of 2024-03-30
Profile
Elizabeth Buck is the founder and currently holds the position of CSO, EVP-Discovery & Translational Sciences at Black Diamond Therapeutics, Inc., which was founded in 2014.
Prior to her current role, she held the position of Assistant Director-Advanced Preclinical at OSI Pharmaceuticals, Inc. from 2005 to 2013.
She also served as the Chief Scientific Officer-Therapeutics at MetaStat, Inc. from 2013 to 2014.
Dr. Buck completed her undergraduate degree at the University of New Hampshire and obtained a doctorate degree from the Icahn School of Medicine at Mount Sinai.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-13 | 95,192 ( 0.18% ) | 482 623 $ | 2024-03-30 |
Elizabeth Buck active positions
| Companies | Position | Start |
|---|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Founder | 2013-12-31 |
Former positions of Elizabeth Buck
| Companies | Position | End |
|---|---|---|
| METASTAT, INC. | Chief Tech/Sci/R&D Officer | 2014-11-30 |
Training of Elizabeth Buck
| University of New Hampshire | Undergraduate Degree |
| Icahn School of Medicine at Mount Sinai | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| METASTAT, INC. | Producer Manufacturing |
| BLACK DIAMOND THERAPEUTICS, INC. | Health Technology |
- Stock Market
- Insiders
- Elizabeth Buck
